Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 12.958.485.937.805.15

What is the latest EV/Core EBITDA ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of GLENMARK PHARMACEUTICALS is 12.95 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202412.95
Mar20238.48
Mar20225.93
Mar20217.80
Mar20205.15

How is EV/Core EBITDA of GLENMARK PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 12.95
52.71
Mar2023 8.48
43.00
Mar2022 5.93
-23.97
Mar2021 7.8
51.46
Mar2020 5.15 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹41,680.9 Cr -7.3% -4.8% 72.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,527.0 Cr -3.8% -3% 34.3% Stock Analytics
DIVIS LABORATORIES ₹156,037.0 Cr 0.9% 0.4% 53.5% Stock Analytics
CIPLA ₹116,854.0 Cr -2.8% -0.1% 9.3% Stock Analytics
DR REDDYS LABORATORIES ₹111,746.0 Cr -2.4% 5.5% 17.5% Stock Analytics
ZYDUS LIFESCIENCES ₹99,093.9 Cr -2.4% -0.3% 42.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-7.3%

-4.8%

72.3%

SENSEX

-1.8%

-6.6%

7.1%


You may also like the below Video Courses